Latest Insider Transactions at Moelis & CO (MC)
This section provides a real-time view of insider transactions for Moelis & CO (MC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Moelis & Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Moelis & Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2023
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
10
+1.01%
|
-
|
|
Dec 22
2023
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
25
+1.03%
|
-
|
|
Dec 22
2023
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.98%
|
-
|
|
Dec 05
2023
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
1,678
-0.97%
|
$85,578
$51.19 P/Share
|
|
Dec 05
2023
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
1,678
+0.96%
|
-
|
|
Nov 13
2023
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Direct |
19,675
-78.75%
|
$806,675
$41.66 P/Share
|
|
Nov 10
2023
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Direct |
50,000
-66.68%
|
$2,050,000
$41.57 P/Share
|
|
Nov 09
2023
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Direct |
23,388
-23.78%
|
$982,296
$42.2 P/Share
|
|
Nov 03
2023
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
612
-0.35%
|
$26,316
$43.77 P/Share
|
|
Nov 03
2023
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
1,391
+0.8%
|
-
|
|
Sep 22
2023
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
17
+1.3%
|
-
|
|
Sep 22
2023
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
31
+1.29%
|
-
|
|
Sep 22
2023
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
14
+1.18%
|
-
|
|
Sep 22
2023
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
3
+1.02%
|
-
|
|
Sep 22
2023
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
32
+1.27%
|
-
|
|
Sep 22
2023
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
30
+1.26%
|
-
|
|
Sep 22
2023
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
17
+1.3%
|
-
|
|
Sep 22
2023
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
31
+1.29%
|
-
|
|
Sep 22
2023
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
29
+1.28%
|
-
|
|
Aug 10
2023
|
Kenneth Shropshire |
SELL
Open market or private sale
|
Direct |
1,417
-16.53%
|
$68,016
$48.09 P/Share
|
|
Aug 02
2023
|
Elizabeth Crain |
SELL
Open market or private sale
|
Direct |
5,588
-100.0%
|
$268,224
$48.06 P/Share
|
|
Jul 31
2023
|
Elizabeth Crain |
SELL
Open market or private sale
|
Direct |
5,588
-50.0%
|
$268,224
$48.1 P/Share
|
|
Jul 27
2023
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
585
-0.34%
|
$30,420
$52.01 P/Share
|
|
Jul 27
2023
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
1,330
+0.77%
|
-
|
|
Jul 03
2023
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
289
+50.0%
|
-
|
|
Jul 03
2023
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
2,446
+50.0%
|
-
|
|
Jul 03
2023
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
1,278
+50.0%
|
-
|
|
Jul 03
2023
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
2,335
+50.0%
|
-
|
|
Jul 03
2023
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
1,278
+50.0%
|
-
|
|
Jul 03
2023
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
2,335
+50.0%
|
-
|
|
Jun 23
2023
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
8
+1.04%
|
-
|
|
Jun 23
2023
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
15
+1.25%
|
-
|
|
Jun 23
2023
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
27
+1.32%
|
-
|
|
Jun 23
2023
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
19
+1.31%
|
-
|
|
Jun 23
2023
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.64%
|
-
|
|
Jun 23
2023
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
31
+1.3%
|
-
|
|
Jun 23
2023
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
20
+1.34%
|
-
|
|
Jun 23
2023
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
4
+0.59%
|
-
|
|
Jun 23
2023
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
30
+1.32%
|
-
|
|
Jun 23
2023
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
19
+1.31%
|
-
|
|
Apr 27
2023
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
570
-0.33%
|
$22,800
$40.6 P/Share
|
|
Apr 27
2023
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
1,294
+0.75%
|
-
|
|
Apr 03
2023
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
13
+50.0%
|
-
|
|
Apr 03
2023
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
309
+50.0%
|
-
|
|
Apr 03
2023
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
66
+50.0%
|
-
|
|
Apr 03
2023
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
309
+50.0%
|
-
|
|
Apr 03
2023
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
77
+50.0%
|
-
|
|
Apr 03
2023
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
132
+50.0%
|
-
|
|
Apr 03
2023
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
342
+50.0%
|
-
|
|
Mar 28
2023
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
2
+1.31%
|
-
|